Chr. Hansen Holding AS (CHR) - Financial and Strategic SWOT Analysis Review

Chr. Hansen Holding AS (CHR) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Chr. Hansen Holding AS (Chr. Hansen) is a developer of natural ingredient solutions for the food, pharmaceutical, nutritional and agricultural industries. The company produces and markets cultures, solutions, enzymes and probiotics. It also produces bacterial solutions for poultry, swine, cattle, and silage. Chr. Hansen’s products are used in cheese and fermented dairy, meat, dietary supplements, infant formula, biofertilizer for fruit and vegetables, animal feed, and wine industries. The company operates production plants and R&D facilities in the US, Germany, Czech Republic, India, and Brazil. It has business presence in Europe, the Middle East and Africa, the Americas and Asia-Pacific. Chr. Hansen is headquartered in Copenhagen, Denmark.

Chr. Hansen Holding AS Key Recent Developments

Oct 12,2023: Chr. Hansen Holding Announces Interim Report Q4 2022/23
Jul 06,2023: Chr. Hansen Holding Announces Interim Report for Q3 2022/23
Apr 13,2023: Chr. Hansen Holding Announces Interim Report Q2 2022/23
Mar 30,2023: Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


List of Tables
List of Figures
Section 1 - About the Company
Chr. Hansen Holding AS - Key Facts
Chr. Hansen Holding AS - Key Employees
Chr. Hansen Holding AS - Key Employee Biographies
Chr. Hansen Holding AS - Major Products and Services
Chr. Hansen Holding AS - History
Chr. Hansen Holding AS - Company Statement
Chr. Hansen Holding AS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Chr. Hansen Holding AS - Business Description
Business Segment: Food Cultures & Enzymes
Overview
Performance
Business Segment: Health & Nutrition
Overview
Performance
Chr. Hansen Holding AS - Corporate Strategy
Chr. Hansen Holding AS - SWOT Analysis
SWOT Analysis - Overview
Chr. Hansen Holding AS - Strengths
Chr. Hansen Holding AS - Weaknesses
Chr. Hansen Holding AS - Opportunities
Chr. Hansen Holding AS - Threats
Chr. Hansen Holding AS - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Chr. Hansen Holding AS, Recent Deals Summary
Section 4 – Company’s Recent Developments
Oct 12, 2023: Chr. Hansen Holding Announces Interim Report Q4 2022/23
Jul 06, 2023: Chr. Hansen Holding Announces Interim Report for Q3 2022/23
Apr 13, 2023: Chr. Hansen Holding Announces Interim Report Q2 2022/23
Mar 30, 2023: Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
Jan 12, 2023: Chr. Hansen Holding Announces Interim Report Q1 2022/23
Dec 12, 2022: Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner
Dec 01, 2022: Sedgwick unifies Nordic operations with appointment of Christian Leif Hansen as Nordic CEO Copenhagen, 1 December
Oct 12, 2022: Chr. Hansen Annual Report 2021/22
Apr 06, 2022: Chr. Hansen reports strong organic growth of 14% for Q2 in a challenging environment
Apr 06, 2022: Chr. Hansen Holding Interim Report Q2 2021/22
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Chr. Hansen Holding AS, Key Facts
Chr. Hansen Holding AS, Key Employees
Chr. Hansen Holding AS, Key Employee Biographies
Chr. Hansen Holding AS, Major Products and Services
Chr. Hansen Holding AS, History
Chr. Hansen Holding AS, Other Locations
Chr. Hansen Holding AS, Subsidiaries
Chr. Hansen Holding AS, Joint Venture
Chr. Hansen Holding AS, Key Competitors
Chr. Hansen Holding AS, Ratios based on current share price
Chr. Hansen Holding AS, Annual Ratios
Chr. Hansen Holding AS, Annual Ratios (Cont...1)
Chr. Hansen Holding AS, Annual Ratios (Cont...2)
Chr. Hansen Holding AS, Interim Ratios
Chr. Hansen Holding AS, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Chr. Hansen Holding AS, Performance Chart (2019 - 2023)
Chr. Hansen Holding AS, Ratio Charts

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings